Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro

The poor prognosis associated with ovarian carcinoma (OVCA) is linked to the high incidence of local recurrence. There is a pressing need to identify factors that can play a role in OVCA growth and spread. Here, we focused on CD40, a member of the tumour necrosis factor (TNF) receptor superfamily with important functions in immune response. The expression of CD40 has been reported on various types of carcinoma cells, but its biological role is still poorly understood. The aim of the present study was to investigate the expression and function of the CD40 in OVCA cell lines. Detectable CD40 levels ranging from low to very high were found on the cell surface of several OVCA cell lines by flow cytometry analysis. Co‐culture with a murine cell line transfected with CD40 ligand (CD40L) inhibited cell growth and up‐regulated the secretion of proinflammatory cytokines interleukin (IL)‐6, IL‐8 and TNF‐α in high‐level CD40‐expressing OVCA cell lines. Similarly, an increase of IL‐6 and IL‐8 release could be obtained by adding a soluble form of CD40L to the OVCA cultures. These results suggest that CD40–CD40L interaction is an important pathway affecting growth regulation and cytokine production in OVCA.

[1]  L. Young,et al.  CD40 and epithelial cells: across the great divide. , 1998, Immunology today.

[2]  A. Armstrong,et al.  EpCAM: A New Therapeutic Target for an Old Cancer Antigen , 2003, Cancer biology & therapy.

[3]  S. Quezada,et al.  CD40/CD154 interactions at the interface of tolerance and immunity. , 2004, Annual review of immunology.

[4]  C. Sautès-Fridman,et al.  Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells. , 2002, The Journal of clinical investigation.

[5]  L. Ferradini,et al.  Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation. , 1999, Cancer research.

[6]  W. Murdoch,et al.  Roles of the ovarian surface epithelium in ovulation and carcinogenesis. , 2002, Reproduction.

[7]  I. Stamenkovic,et al.  Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma. , 1999, Journal of immunology.

[8]  J. Banchereau,et al.  Fas ligation induces apoptosis of CD40-activated human B lymphocytes , 1995, The Journal of experimental medicine.

[9]  Zhengfan Jiang,et al.  Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Hess,et al.  Expression of metastasis-related genes in human epithelial ovarian tumors. , 2002, International journal of oncology.

[11]  W. Foulkes,et al.  Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. , 1993, The Journal of clinical investigation.

[12]  D. Taub,et al.  Role for CD40-CD40 ligand interactions in the immune response to solid tumours. , 2000, Molecular immunology.

[13]  Stephen P. Schoenberger,et al.  T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.

[14]  F. Kikkawa,et al.  Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma. , 1997, Anticancer research.

[15]  C. Sautès-Fridman,et al.  Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells , 2002 .

[16]  D. Taub,et al.  Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. , 1999, Blood.

[17]  S. Paulie,et al.  Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis , 1998, International journal of cancer.

[18]  Zhengfan Jiang,et al.  Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[20]  J. Crocker,et al.  CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion , 2002, Molecular pathology : MP.

[21]  P. Hersey,et al.  Expression of the co‐stimulatory molecule CD40 on melanoma cells , 1996 .

[22]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[23]  I. Fidler,et al.  Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. , 2005, Cancer research.

[24]  M. McKay,et al.  Cancer of the ovary. , 1994, The New England journal of medicine.

[25]  F. Bouet,et al.  Constitutive expression of TGF-bêta1, interleukin-6 and interleukin-8 by tumor cells as a major component of immune escape in human ovarian carcinoma. , 2003, European cytokine network.